Trial Outcomes & Findings for Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control. (NCT NCT06892834)

NCT ID: NCT06892834

Last Updated: 2026-05-04

Results Overview

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

120 participants

Primary outcome timeframe

4 weeks (~1 month) and 12 weeks (~3 months)

Results posted on

2026-05-04

Participant Flow

Participant milestones

Participant milestones
Measure
Negative Control
0.76% Sodium Monofluorophosphate
Experimental #1
0.243% NaF with 0.1% Hops, Humulus lupulus extract \[0.045% hops β-acids\]
Experimental #2
0.243% NaF with 0.5% Hops, Humulus lupulus extract \[0.225% hops β-acids\]
Positive Control
0.454% stannous fluoride, 0.533% zinc citrate
Overall Study
STARTED
30
30
30
30
Overall Study
COMPLETED
30
30
30
30
Overall Study
NOT COMPLETED
0
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Negative Control
n=30 Participants
0.76% Sodium Monofluorophosphate Sodium monofluorophosphate dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.
Experimental #1
n=30 Participants
0.243% NaF with 0.1% Hops, Humulus lupulus extract \[0.045% hops β-acids\] Sodium Fluoride Dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.
Experimental #2
n=30 Participants
0.243% NaF with 0.5% Hops, Humulus lupulus extract \[0.225% hops β-acids\] Sodium Fluoride Dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.
Positive Control
n=30 Participants
0.454% stannous fluoride, 0.533% zinc citrate Stannous Fluoride Dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.
Total
n=120 Participants
Total of all reporting groups
Age, Continuous
46.00 years
STANDARD_DEVIATION 15.326 • n=54 Participants
51.20 years
STANDARD_DEVIATION 14.639 • n=60 Participants
48.23 years
STANDARD_DEVIATION 15.664 • n=114 Participants
43.63 years
STANDARD_DEVIATION 16.155 • n=1 Participants
47.27 years
STANDARD_DEVIATION 15.516 • n=9 Participants
Sex: Female, Male
Female
20 Participants
n=54 Participants
20 Participants
n=60 Participants
22 Participants
n=114 Participants
20 Participants
n=1 Participants
82 Participants
n=9 Participants
Sex: Female, Male
Male
10 Participants
n=54 Participants
10 Participants
n=60 Participants
8 Participants
n=114 Participants
10 Participants
n=1 Participants
38 Participants
n=9 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=54 Participants
1 Participants
n=60 Participants
1 Participants
n=114 Participants
1 Participants
n=1 Participants
4 Participants
n=9 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
29 Participants
n=54 Participants
29 Participants
n=60 Participants
29 Participants
n=114 Participants
29 Participants
n=1 Participants
116 Participants
n=9 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=54 Participants
0 Participants
n=60 Participants
0 Participants
n=114 Participants
0 Participants
n=1 Participants
0 Participants
n=9 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=54 Participants
0 Participants
n=60 Participants
0 Participants
n=114 Participants
0 Participants
n=1 Participants
0 Participants
n=9 Participants
Race (NIH/OMB)
Asian
4 Participants
n=54 Participants
6 Participants
n=60 Participants
9 Participants
n=114 Participants
8 Participants
n=1 Participants
27 Participants
n=9 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=54 Participants
0 Participants
n=60 Participants
0 Participants
n=114 Participants
0 Participants
n=1 Participants
0 Participants
n=9 Participants
Race (NIH/OMB)
Black or African American
13 Participants
n=54 Participants
5 Participants
n=60 Participants
12 Participants
n=114 Participants
11 Participants
n=1 Participants
41 Participants
n=9 Participants
Race (NIH/OMB)
White
13 Participants
n=54 Participants
18 Participants
n=60 Participants
9 Participants
n=114 Participants
11 Participants
n=1 Participants
51 Participants
n=9 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=54 Participants
1 Participants
n=60 Participants
0 Participants
n=114 Participants
0 Participants
n=1 Participants
1 Participants
n=9 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=54 Participants
0 Participants
n=60 Participants
0 Participants
n=114 Participants
0 Participants
n=1 Participants
0 Participants
n=9 Participants
Region of Enrollment
Canada
30 participants
n=54 Participants
30 participants
n=60 Participants
30 participants
n=114 Participants
30 participants
n=1 Participants
120 participants
n=9 Participants

PRIMARY outcome

Timeframe: 4 weeks (~1 month) and 12 weeks (~3 months)

Population: Number of Bleeding sites

Outcome measures

Outcome measures
Measure
Negative Control
n=30 Participants
0.76% Sodium Monofluorophosphate Sodium monofluorophosphate dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.
Experimental #1
n=30 Participants
0.243% NaF with 0.1% Hops, Humulus lupulus extract \[0.045% hops β-acids\] Sodium Fluoride Dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.
Experimental #2
n=30 Participants
0.243% NaF with 0.5% Hops, Humulus lupulus extract \[0.225% hops β-acids\] Sodium Fluoride Dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.
Positive Control
n=30 Participants
0.454% stannous fluoride, 0.533% zinc citrate Stannous Fluoride Dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.
Number Bleeding Sites
4 weeks (~1 month)
31.52 number of bleeding sites
Standard Error 0.471
25.90 number of bleeding sites
Standard Error 0.700
21.65 number of bleeding sites
Standard Error 0.507
19.13 number of bleeding sites
Standard Error 1.017
Number Bleeding Sites
12 weeks (~3 Months)
28.37 number of bleeding sites
Standard Error 0.555
20.18 number of bleeding sites
Standard Error 0.700
13.92 number of bleeding sites
Standard Error 0.443
9.22 number of bleeding sites
Standard Error 0.866

SECONDARY outcome

Timeframe: 4 weeks (~1 month) and 12 weeks (~3 months)

scored on a scale of 0-3; 0 Normal gingiva; 1 Mild inflammation - slight change in colour, slight edema. No bleeding on probing; 2 Moderate inflammation - redness, edema, and glazing. Bleeding on probing; 3 Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding

Outcome measures

Outcome measures
Measure
Negative Control
n=30 Participants
0.76% Sodium Monofluorophosphate Sodium monofluorophosphate dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.
Experimental #1
n=30 Participants
0.243% NaF with 0.1% Hops, Humulus lupulus extract \[0.045% hops β-acids\] Sodium Fluoride Dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.
Experimental #2
n=30 Participants
0.243% NaF with 0.5% Hops, Humulus lupulus extract \[0.225% hops β-acids\] Sodium Fluoride Dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.
Positive Control
n=30 Participants
0.454% stannous fluoride, 0.533% zinc citrate Stannous Fluoride Dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.
Löe-Silness Gingivitis Evaluation
1 Month
1.18 score on scale
Standard Error 0.006
1.11 score on scale
Standard Error 0.005
1.07 score on scale
Standard Error 0.006
1.06 score on scale
Standard Error 0.009
Löe-Silness Gingivitis Evaluation
3 Months
1.16 score on scale
Standard Error 0.006
1.06 score on scale
Standard Error 0.007
0.98 score on scale
Standard Error 0.012
0.93 score on scale
Standard Error 0.010

Adverse Events

Positive Control

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Experimental #1

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Experimental #2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Negative Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Positive Control
n=30 participants at risk
0.454% stannous fluoride, 0.533% zinc citrate Stannous Fluoride Dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 12 weeks (\~3 months).
Experimental #1
n=30 participants at risk
0.243% NaF with 0.1% Hops, Humulus lupulus extract \[0.045% hops β-acids\] Sodium Fluoride Dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 12 weeks (\~3 months).
Experimental #2
n=30 participants at risk
0.243% NaF with 0.5% Hops, Humulus lupulus extract \[0.225% hops β-acids\] Sodium Fluoride Dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 12 weeks (\~3 months).
Negative Control
n=30 participants at risk
0.76% Sodium Monofluorophosphate Sodium monofluorophosphate dentifrice: Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 12 weeks (\~3 months).
Nervous system disorders
HEADACHE
6.7%
2/30 • Number of events 2 • Data collected over 12 weeks (~3 months) of product use.
0.00%
0/30 • Data collected over 12 weeks (~3 months) of product use.
0.00%
0/30 • Data collected over 12 weeks (~3 months) of product use.
0.00%
0/30 • Data collected over 12 weeks (~3 months) of product use.

Additional Information

Dr. Tao He

Procter & Gamble

Phone: 513-622-2159

Results disclosure agreements

  • Principal investigator is a sponsor employee The PI agrees not to publish the results of a study without the prior written consent of Sponsor.
  • Publication restrictions are in place

Restriction type: OTHER